Dr Anna Kirby, Breast Cancer Radiotherapy Team
HeartSpare Plus: Chief Investigator
This study aims to identify and evaluate optimal radiotherapy techniques for treating locoregional lymph nodes in women with lymph-node positive breast cancer whilst limiting the dose to normal tissues, in order to reduce the risks of radiation-induced heart disease and second cancers.
CORE Trial: Breast Lead Co-Investigator
This trial is evaluating the role of stereotactic radiotherapy in treating small-volume metastatic disease.
Quartus Study: Principal Investigator
This study is using novel ultrasound techniques to evaluate patients who develop breast swelling and hardness following breast radiotherapy.
PRADA Study: Co-Investigator
The PRADA study is investigating whether reversing the order of mastectomy with immediate DIEP flap reconstruction and adjuvant radiotherapy is safe, with a view to improving cosmetic outcomes in women requiring breast radiotherapy and DIEP flap reconstruction.
IMPORT Trials>: Chief Clinical Co-Ordinator
These trials are evaluating partial breast irradiation and simultaneous integrated boost in women at low and high risk of relapse respectively.
BRITER Study: Principal Investigator
A Randomised Clinical Trial comparing the use of dark ink and fluorescent (“invisible”) tattoos
Cancer Research UK
National Institute for Health Research “Research for Patient Benefit” Programme